Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Clofazimine effectively treated ashy dermatosis in a patient.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

A new method was developed to purify finasteride for better medical use.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

The new compound may be a safer alternative to finasteride for prostate protection.

Spironolactone is a promising alternative to antibiotics for treating acne in adult females.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Diclofenac salt delivery through skin varies based on the salt's counterions.

Pharmacists play a crucial role in customizing treatments and ensuring medication safety.